Chief Financial Officer of Flexion Therapeutics Inc (NASDAQ:FLXN), Arkowitz David, sells 6,073 shares worth $67,592
According to Flexion Therapeutics Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 07 05:50 PM, company Chief Financial Officer, Arkowitz David disclosed selling 6,073 shares at a cost of $11.13. At the time of this transaction (Jan 05), this trade was worth $67,592 in total. As of Jan 05, Arkowitz David now owns 151,048 shares in total worth about $1,889,610.48.
For the last few recent trades made by Flexion Therapeutics Inc (NASDAQ:FLXN) Chief Financial Officer, Arkowitz David, we have the following information:
- SEC Form 4 filing: May 07: Sold 2,413 shares at the rate of $10.88 per share. Total worth of this trade was $26,253. Total number of shares owned as of May 07 were 117,068
- SEC Form 4 filing: May 08: Sold 2,248 shares at the rate of $10.06 per share. Total worth of this trade was $22,615. Total number of shares owned as of May 08 were 82,924
Posted by
George Daniels
on Thursday January 07 2021, 6:14 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
